ANI Pharmaceuticals | ANIP - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
AbbVie USD 5.57B 2.9B 2026-03
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Assertio Holdings USD -2.88M 648K 2024-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 5.17B 637M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Perrigo USD -1.33B 1.35B 2025-12
Sun Pharmaceuticals INR 41.68B 9.95B 2025-09
Teva Pharmaceutical Industries USD 753M 662M 2026-03